← Back to headlines
J&J’s new psoriasis pill to rival AbbVie’s Skyrizi: BNP Paribas
J&J's new psoriasis pill is expected to compete with AbbVie's Skyrizi, according to BNP Paribas.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Spain Records Over 5,000 Heat-Related Deaths During Unprecedented Summer
1h ago
Singer Lionel Richie Hospitalized in ICU Following Concert Medical Episode
1h ago
Croatia Launches Mosquito Control Campaign Amid West Nile Virus Outbreak
3h ago
Lionel Richie Hospitalized in ICU Following St. Louis Concert
5h ago